Department of Obstetrics & Gynaecology, University "Magna Graecia" of Catanzaro, Viale Europa, Catanzaro, Italy.
Gynecol Endocrinol. 2012 Sep;28(9):710-21. doi: 10.3109/09513590.2011.652247. Epub 2012 Feb 17.
Nexplanon(®) is a new long-term reversible contraception method. The current review is aimed to analyze the published data concerning the contraceptive effectiveness of Nexplanon(®) and its effects on reproductive function. Pharmacological properties and technical procedures of insertion and removal, as well as the efficacy and safety data available, were discussed. Possible strategies for treating Nexplanon(®)-related bleeding were also described. With regard to the future research and the future scientific developments of contraceptive implants, the possible use of Nexplanon(®) wide-ranging for the symptomatic treatment of endometriosis and premenstrual syndrome (PMS) were considered. Finally, it was defined in which women the use of Nexplanon(®) is indicated and in which it is contra-indicated.
Nexplanon（®）是一种新的长效可逆避孕方法。目前的综述旨在分析已发表的关于 Nexplanon（®）避孕效果及其对生殖功能影响的数据。讨论了药物特性、插入和取出的技术程序以及现有的疗效和安全性数据。还描述了治疗与 Nexplanon（®）相关出血的可能策略。关于未来的研究和避孕植入物的未来科学发展，考虑了将 Nexplanon（®）广泛用于子宫内膜异位症和经前期综合征（PMS）的症状治疗。最后，确定了哪些女性适合使用 Nexplanon（®），哪些女性禁用。
